Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin vs platelet-rich plasma for plantar fasciitis
2018-000575-32Phase 4Active
- Sponsor
- Isabel Maria Ruiz
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes, Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A and autologous platelet-rich plasma in plantar fasciitis (3 arms), sponsored by Isabel Maria Ruiz. Primary endpoint: Pain (VAS). Started Nov 2018; status: active.
02
Drugs
botulinum toxin type Aautologous platelet-rich plasma
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on 2018-000575-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000575-32.